Does USTEKINUMAB Cause Peripheral venous disease? 878 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 878 reports of Peripheral venous disease have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 1.0% of all adverse event reports for USTEKINUMAB.
878
Reports of Peripheral venous disease with USTEKINUMAB
1.0%
of all USTEKINUMAB reports
752
Deaths
814
Hospitalizations
How Dangerous Is Peripheral venous disease From USTEKINUMAB?
Of the 878 reports, 752 (85.6%) resulted in death, 814 (92.7%) required hospitalization, and 821 (93.5%) were considered life-threatening.
Is Peripheral venous disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 878 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Peripheral venous disease?
RITUXIMAB (1,281)
ADALIMUMAB (1,249)
METHOTREXATE (1,246)
SECUKINUMAB (1,186)
ABATACEPT (1,168)
DICLOFENAC (1,168)
LEFLUNOMIDE (1,154)
TOCILIZUMAB (1,137)
PREDNISONE (1,101)
ALENDRONATE (1,097)
Which USTEKINUMAB Alternatives Have Lower Peripheral venous disease Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE